Treatment Details – 8.8 months

Survival: 8.8 months
  
Toxicity Grade:4
  
Treatments: Chemotherapy
  
Drugs: Vepesid
Country:Netherlands
  
City/State/Province:Amsterdam
  
Hospital:University Hospital Vrije Universiteit
  
Journal:Link
  
Date: 11/1997

Description:
Patients: This Phase II trial involved 41 patients with malignant pleural mesothelioma.

Treatment: The treatment consisted of a chemotherapy drug, oral etoposide (VP 16-213, vepesid).

Toxicity: Grade 3-4 toxicities included hematological, nausea/vomiting, cutaneous reaction, and alopecia.

Results: Median survival was 38 weeks (8.8 months).

Get your free copy of
“Surviving Mesothelioma” Today!